Market Capitalization Changement Date
AbbVie USD 273.6B 10.51B 2023-12
ALKERMES USD 4.63B 36M 2023-12
Amgen USD 154.14B 10.38B 2023-12
AstraZeneca GBP 164.29B 7.78B 2023-12
Biogen USD 37.5B 274M 2023-12
BioMarin Pharmaceutical USD 18.16B 1.51B 2023-12
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Gilead Sciences USD 100.94B 7.57B 2023-12
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Infinity Pharmaceuticals USD 19M 5M 2023-06
Medtronic USD 109.54B 5.28B 2023-12
Merck USD 314.33B 38.07B 2024-03
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pacira USD 1.33B 234M 2024-03
Perrigo USD 4.33B 268M 2023-09
Pfizer USD 155.51B 7.05B 2024-03
Regeneron Pharmaceuticals USD 106.74B 11.05B 2024-03
Revance Therapeutics USD 772M 237M 2023-12
Roche Holding CHF 199.67B 23.81B 2023-12
Sanofi EUR 113.53B 14.8B 2023-12
UCB EUR 15.79B 1.54B 2023-06
Ultragenyx Pharmaceutical USD 3.77B 153M 2024-03
United Therapeutics USD 11.05B 721M 2024-03
Vertex Pharmaceuticals USD 106.53B 1.68B 2024-03
Zoetis USD 77.28B 13.34B 2024-03



AbbVie Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.